A Self-management Programme of Activity Coping and Education for Chronic Obstructive Pulmonary Disease: is it effective in primary care?

ISRCTN ISRCTN35501175
DOI https://doi.org/10.1186/ISRCTN35501175
Protocol serial number N/A
Sponsor University Hospitals of Leicester NHS Trust (UK)
Funder National Institute for Health Research (NIHR) (UK) - Collaboration in Applied Health Research and Care for Leicestershire, Northamptonshire and Rutland (CLAHRC-LNR)
Submission date
25/08/2009
Registration date
08/04/2010
Last edited
10/11/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Sally Singh
Scientific

Department of Pulmonary Rehabilitation
Glenfield Hospital
Leicester
LE3 9QP
United Kingdom

Phone +44 (0)116 250 2350
Email sally.singh@uhl-tr.nhs.uk

Study information

Primary study designInterventional
Study designParallel-group randomised clinical trial
Secondary study designRandomised parallel trial
Study type Participant information sheet
Scientific titleA randomised controlled trial to evaluate the effectiveness of a Self-management Programme of Activity Coping and Education for Chronic Obstructive Pulmonary Disease delivered in primary care
Study acronymSPACE for COPD
Study objectivesThe hypothesis is that a structured education and self-management programme for patients with chronic obstructive pulmonary disease (COPD) will promote independence and improve their quality of life and physical function.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedChronic obstructive pulmonary disease
InterventionParticipants in the intervention group will receive a 171-page A4 workbook comprising sections on disease education, stress management strategies, breathing control advice and techniques to improve exercise capacity and levels of domestic physical activity. It also includes an individual action plan designed to help cope with exacerbations. Motivational telephone calls will be made at 2 and 5 weeks, 3 and 5 months to encourage participants to complete the manual and pursue an active lifestyle. It is anticipated that participants will have worked through the manual in approximately eight weeks.

The control group arm will be monitored in primary care according to the practice framework. Changes in medication during the study period will be recorded. Participants in this group will receive telephone contact to check for GP and hospital contacts and to arrange follow-up visits.

Outcome measures will be collected at the initial assessment, and eight weeks and six months after this assessment to determine the short and medium term effects for both study groups.
Intervention typeOther
Primary outcome measure(s)

Health status determined by Chronic Respiratory Disease Self-Reported Questionnaire - dyspnoea component, measured at the initial assessment, and at 8 weeks and 6 months after this assessment

Key secondary outcome measure(s)

Measured at the initial assessment, and at 8 weeks and 6 months after this assessment:
1. Domestic physical activity
2. Exercise capacity
3. Mental wellbeing
4. Self-efficacy
5. Health utilisation
6. Task completion
7. Adherence
8. Patient knowledge
9. Exacerbation rates

Completion date30/09/2012

Eligibility

Participant type(s)Patient
Age groupAll
SexAll
Target sample size at registration192
Key inclusion criteriaPatients (no age limit, either sex) with an established diagnosis of COPD according to international guidelines and Medical Research Council (MRC) dyspnoea scale 2 - 5.
Key exclusion criteria1. Inability to participate in interventions designed to improve physical capacity, e.g., neurological, locomotive or psychiatric disability
2. Unwillingness to participate
3. Participation in other research projects
4. Inability to read English
5. Participation in rehabilitation in the last 12 months
6. Patients must have been clinically stable for four weeks
Date of first enrolment30/09/2009
Date of final enrolment30/09/2012

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Glenfield Hospital
Leicester
LE3 9QP
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2014 Yes No
Other publications economic evaluation 01/02/2016 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

10/11/2016: Publication reference added.